Streptococcus thermophilus
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Streptococcus thermophilus is a bacterial culture indicated in some treatments of diarrhea.
- Generic Name
- Streptococcus thermophilus
- DrugBank Accession Number
- DB16548
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- S. thermophilus
- Streptococcus salivarius subsp. thermophilus
- Streptococcus salivarius thermophilus
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat Diarrhea Combination Product in combination with: Lactobacillus acidophilus (DB15823), Lactobacillus delbrueckii bulgaricus (DB16540) ••• ••• ••••••• ••• •••••••••• Treatment of Diarrhea ••• ••• ••••••• ••• •••••••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image MORELAC Streptococcus thermophilus (4000000000 CFU) + Lactobacillus acidophilus (10000000 CFU) + Lactobacillus delbrueckii bulgaricus (5000000 CFU) Powder, for suspension Oral Proge Farm S.R.L. 2014-07-08 Not applicable Italy
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- T8F3MOB0CG
- CAS number
- Not Available
References
- General References
- AIFA: Endolac (Streptococcus thermophilus) Oral Powder for Suspension [Link]
- External Links
- 2593692
- Wikipedia
- Streptococcus_thermophilus
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Powder, for suspension Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at February 05, 2021 19:29 / Updated at May 05, 2021 20:32